Fc receptor like 3 in Chinese patients of Han nationality with Guillain-Barré syndrome

Journal of Neuroimmunology

Volumn 246, Issue 1-2, 2012, Pages 65-68

  Sang, Daoqian ^a   Chen, Qiming ^a   Liu, Xiaolin ^a   Qu, Hongdang ^a   Wei, Daoxiang ^a   Yin, Liang ^a   Zhang, Lina ^a  

^a BENGBU MEDICAL COLLEGE   (China)

Author keywords

Fc receptor like 3; Guillain Barr syndrome; Haplotype; Single nucleotide polymorphism

Indexed keywords

GANGLIOSIDE GM1 ANTIBODY; GENOMIC DNA;

ADULT; ALLELE; ARTICLE; CHINESE; COHORT ANALYSIS; CONTROLLED STUDY; EXON; FC RECEPTOR LIKE 3 GENE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; GUILLAIN BARRE SYNDROME; HAPLOTYPE; HUMAN; IMMUNOPATHOGENESIS; INTRON; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MUTATIONAL ANALYSIS; PRIORITY JOURNAL; RECEPTOR GENE; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; DOWN-REGULATION; GENE FREQUENCY; GUILLAIN-BARRE SYNDROME; HAPLOTYPES; HUMANS; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, IMMUNOLOGIC; UP-REGULATION;

EID: 84862785830     PISSN: 01655728     EISSN: 18728421     Source Type: Journal    
DOI: 10.1016/j.jneuroim.2012.03.006     Document Type: Article

References (32)

1. Allos B.M. Association between Campylobacter infection and Guillain-Barré syndrome. J. Infect. Dis. 1997, 176:S125-S128.
2. Alter M. The epidemiology of Guillain-Barré syndrome. Ann. Neurol. 1990, 27:S7-S12. (Suppl.).
3. Asbury A.K., Cornblath D.R. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann. Neurol. 1990, 27:S21-S24.
4. Caporale C.M., Papola F., Fioroni M.A., Aurelib A., Giovanninic A., Notturnoa F., Adornob D., Caporalec V., Uncinia A. Susceptibility to Guillain-Barré syndrome is associated to polymorphisms of CD1 genes. J. Neuroimmunol. 2006, 177:112-118.
5. Davis R.S., Wang Y.H., Kubagawa H., Cooper M.D. Identification of a family of Fc receptor homologs with preferential B cell expression. Proc. Natl. Acad. Sci. U. S. A. 2001, 98:9772-9777.
6. Davis R.S., Dennis G., Odom M.R., Gibson A.W., Kimberly R.P., Gibson A.W., Kimberly R.P., Burrows P.D., Cooper M.D. Fc receptor homologs: newest members of a remarkably diverse Fc receptor gene family. Immunol. Rev. 2002, 190:123-136.
7. Davis R.S., Dennis G., Kubagawa H., Cooper M.D. Fc receptor homologs (FcRH1-5) extend the Fc receptor family. Curr. Top. Microbiol. Immunol. 2002, 266:85-112.
8. Downes K., Barratt B.J., Akan P., Bumpstead S.J., Taylor S.D., Clayton D.G., Deloukas P. SNP allele frequency estimation in DNA pools and variance components analysis. Biotechniques 2004, 36:840-845.
9. Gabriel S.B., Schaffner S.F., Nguyen H., Moore1 J.M., Roy J., Blumenstiel B., Higgins J., DeFelice M., Lochner A., Faggart M., Liu-Cordero S.N., Rotimi C., Adeyemo A., Cooper R., Ward R., Lander E.S., Daly M.J., Altshuler D. The structure of haplotype blocks in the human genome. Science 2002, 296(5576):2225-2229.
10. Geleijns K., Jacobs B.C., Van Rijs W., Tio-Gillenab A.P., Lamanb J.D., Van Doorna P.A. Functional polymorphisms in LPS receptors CD14 and TLR4 are not associated with disease susceptibility or Campylobacter jejuni infection in Guillain-Barré patients. J. Neuroimmunol. 2004, 150:132-138.
11. Geleijns K., Schreuder G.M.T., Jacobs B.C., Sintnicolaas K., Van Koningsveld R., Meulstee J., Laman J.D., Van Doorn P.A. HLA class II alleles are not a general susceptibility factor in Guillain-Barré syndrome. Neurology 2005, 64:44-49.
12. Geleijns K., Laman J.D., Van Rijs W., Tio-Gillenab A.P., Hintzena R.Q., Van Doorna P.A., Jacobsab B.C. Fas polymorphisms are associated with the presence of anti-ganglioside antibodies in Guillain-Barré syndrome. J. Neuroimmunol. 2005, 161:183-189.
13. Hadden R.D., Cornblath D.R., Hughes R.A., Zielasek J., Hartung H.P., Toyka K.V., Swan A.V. Electrophysiological classification of Guillain-Barré syndrome: clinical association and outcome. Ann. Neurol. 1998, 44:780-788.
14. Haifeng L., Jinmei Y., Hongjun H., Zheng Y., Shenwu W. HLA alleles in patients with Guillain-Barré syndrome. Chin. Med. J. 2000, 113:429-432.
15. Ho T.W., McKhann G.M., Griffin J.M. Human autoimmune neuropathies. Annu. Rev. Neurosci. 1998, 21:187-226.
16. Kochi Y., Yamada R., Suzuki A., Harley J.B., Shirasawa S., Sawada T., Bae S.C., Tokuhiro S., Chang X., Sekine A., Takahashi A., Tsunoda T., Ohnishi Y., Kaufman K.M., Kang C.P., Kang C., Otsubo S., Yumura W., Mimori A., Koike T., Nakamura Y., Sasazuki T., Yamamoto K. A functional variant in FcRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities. Nat. Genet. 2005, 37:478-485.
17. Kochi Y., Myouzen K., Yamada R., Suzuki A., Kurosaki T., Nakamura Y., Yamamoto K. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling. J. Neuroimmunol. 2009, 183:5502-5510.
18. Magira E.E., Papaioakim M., Nachamkin I., Asbury A.K., Li C.Y., Ho T.W., Griffin J.W., McKhann G.M., Monos D.S. Differential distribution of HLA-DQβ/DRβ epitopes in the two forms of Guillain-Barré syndrome, acute motor axonal neuropathy and acute inflammatory demyelinating Polyneuropathy (AIDP): identification of DQβ epitopes associated with susceptibility to and protection from AIDP. J. Immunol. 2003, 170:3074-3080.
19. McCombe P.A., Csurhes P.A., Greer J.M. Studies of HLA associations in male and female patients with Guillain-Barré syndrome (GBS) and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). J. Neuroimmunol. 2006, 180:172-177.
20. Myhr K.M., Vågnes K.S., Marøy T.H., Aarseth J.H., Nyland H.I., Vedeler C.A. Interleukin-10 promoter polymorphisms in patients with Guillain-Barré syndrome. J. Neuroimmunol. 2003, 139:81-83.
21. Nagata S., Ise T., Pastan I. Fc receptor-like 3 protein expressed on IL-2 nonresponsive subset of human regulatory T cells. J. Immunol. 2009, 182:7518-7526.
22. Sakaguchi S., Yamaguchi T., Nomura T., Ono M. Regulatory T cells and immune tolerance. Cell 2008, 133:775-787.
23. +regulatory T cells. Immunol. Rev. 2006, 212:60-73.
24. Siminovitch K.A. PTPN22 and autoimmune disease. Nat. Genet. 2004, 36:1248-1249.
25. Stephens M., Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am. J. Hum. Genet. 2003, 73:1162-1169.
26. Stephens M., Smith N., Donnelly P. A new statistical method for haplotype reconstruction from population data. Am. J. Hum. Genet. 2001, 68:978-989.
27. Swainson L.A., Mold J.E., Bajpai U.D., McCune J.M. Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high Levels of programmed cell death-1. J. Immunol. 2010, 184:3639-3647.
28. van der Meché F.G., van Doorn P.A., Meulstee J., Jennekens F.G. Diagnostic and classification criteria for the Guillain-Barré syndrome. Eur. Neurol. 2001, 45:133-139.
29. Van der Pol W.L., Van den Berg L.H., Scheepers R.H., Van der Bom J.D., Van Doorn P.A., Van Koningsveld R., Van den Broek M.C.L., Wokke J.H.J., Van de Winkel J.G.J. IgG receptor IIa alleles determine susceptibility and severity of Guillain-Barré syndrome. Neurology 2000, 54:1661-1665.
30. Van Sorge N.M., Van der Pol W.L., Jansen M.D., Geleijnsde K.P.W., Kalmijnc S., Hughesg R.A.C., Reesj J.H., Pritchardg J., Vedeleri C.A., Myhri K.M., Shawh C., Van Schaikf I.N., Wokkea J.H.J., Van Doornd P.A., Jacobsde B.C., Van de Winkelbk J.G.J., Van den Berga L.H. Severity of Guillain-Barré syndrome is associated with Fcγ Receptor III polymorphisms. J. Neuroimmunol. 2005, 162:157-164.
31. Vedeler C.A., Raknes G., Myhr K.M., Nyland H. IgG Fc-receptor polymorphisms in Guillain-Barré syndrome. Neurology 2000, 55:705-707.
32. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat. Rev. Immunol. 2008, 8:523-532.